CD3 T-cell engagers have the potential to be a cornerstone of cancer treatment. They guide the immune system to find and ...

In March 2025, Celgene announced a study is to compare the effectiveness and safety of golcadomide in combination with ...

A groundbreaking study published in Research (2025, DOI: 10.34133/research.0545) has elucidated the molecular mechanisms by which protein phosphatase 2A (PP2A) regulates CD8+ T cell-mediated immune ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and ...

We are delighted to welcome Stephen to TScan at this stage of growth for the Company,” said Gavin MacBeath, Ph.D., Chief Executive Officer. “His robust commercial leadership experience includes over ...

With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...

As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...

Extracts made from parts of the cashew plant that are usually thrown away when the nuts are processed commercially were found ...

Mouse study reveals beneficial bacteria play crucial role in helping insulin-producing cells multiply. Exposure to ...